Therapeutic strategy utilizing mechanical circulatory supports in patients with pheochromo-cytoma-related cardiogenic shock remains unestablished. We had a 51-year-old man with acute decompensated heart failure due to pheochromocytoma crisis. He received a percutaneous left ventricular assist device-supported alpha-blocker and intensive fluid infusion therapy, which amelio-rated impaired end-organ dysfunction, maintaining hemodynamics and achieving cardiac recovery, followed by the successfully scheduled adrenalectomy. Early suspicion of pheochromocytoma and Impella-supported disease-specific medical management might be a promising bridge to surgery strategy.
CITATION STYLE
Nakamura, M., Imamura, T., Fukui, T., Oshima, A., Ueno, H., & Kinugawa, K. (2022). Successful Management of Pheochromocytoma Crisis with Cardiogenic Shock by Percutaneous Left Ventricular Assist Device. Journal of Cardiovascular Development and Disease, 9(3). https://doi.org/10.3390/jcdd9030071
Mendeley helps you to discover research relevant for your work.